HOSPITAL UNIVERSITARIO RUBER
Departamento
Yonsei University
Seúl, Corea del SurPublicacións en colaboración con investigadores/as de Yonsei University (3)
2023
-
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
JAMA network open, Vol. 6, Núm. 11, pp. e2342107